NORTRIPTYLINE HYDROCHLORIDE

NORTRIPTYLINE HYDROCHLORIDE was reported 5962 times

NORTRIPTYLINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLEURAL RUB 8 0.2424
1 PRESBYACUSIS 55 0.1786
2 CEREBRAL HYPOPERFUSION 63 0.1352
3 TEMPERATURE REGULATION DISORDER 285 0.1278
4 BINOCULAR EYE MOVEMENT DISORDER 30 0.1042
5 VASCULAR MALFORMATION 17 0.0810
6 PLEURAL THICKENING 53 0.0775
7 CEREBELLAR STROKE 30 0.0767
8 ANAL HYPOAESTHESIA 5 0.0735
9 PARANASAL CYST 17 0.0700
10 BONE HYPERTROPHY 11 0.0683
11 POST-TRAUMATIC HEADACHE 10 0.0637
12 BLOOD MAGNESIUM INCREASED 53 0.0588
13 PLEURAL FIBROSIS 56 0.0550
14 FOOD ALLERGY 380 0.0492
15 REVERSIBLE AIRWAYS OBSTRUCTION 24 0.0472
16 FOETAL DEATH 216 0.0416
17 BONE CYST 39 0.0416
18 VASCULAR GRAFT OCCLUSION 14 0.0365
19 NEOVASCULARISATION 7 0.0266
20 SPONDYLOLYSIS 5 0.0266
21 IMMUNODEFICIENCY 396 0.0265
22 HAEMANGIOMA OF BONE 5 0.0262
23 OSTEOSCLEROSIS 41 0.0260
24 COELIAC DISEASE 246 0.0251
25 MASTOIDITIS 24 0.0245
26 IODINE ALLERGY 8 0.0240
27 ANTIDEPRESSANT DRUG LEVEL INCREASED 8 0.0225
28 BURSITIS 261 0.0215
29 NEUROGENIC BOWEL 5 0.0209
30 RADICULAR PAIN 7 0.0201
31 PRODUCT USED FOR UNKNOWN INDICATION 24 0.0191
32 DEAFNESS NEUROSENSORY 62 0.0188
33 PRESCRIBED OVERDOSE 337 0.0174
34 SLEEP ATTACKS 8 0.0168
35 RELAPSING MULTIPLE SCLEROSIS 5 0.0166
36 HYPORESPONSIVE TO STIMULI 19 0.0162
37 MUSCLE TONE DISORDER 5 0.0160
38 EPIGASTRIC DISCOMFORT 53 0.0136
39 BRUGADA SYNDROME 14 0.0135
40 PIGMENTARY MACULOPATHY 6 0.0124
41 SLOW RESPONSE TO STIMULI 15 0.0116
42 ABULIA 10 0.0108
43 ALANINE AMINOTRANSFERASE ABNORMAL 22 0.0104
44 CONTRAINDICATED PRODUCT ADMINISTERED 295 0.0097
45 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 22 0.0095
46 PNEUMONIA ASPIRATION 216 0.0086
47 FEELINGS OF WORTHLESSNESS 11 0.0084
48 UPPER RESPIRATORY TRACT INFECTION 387 0.0084
49 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 5 0.0077
50 SPINAL CORD INJURY 13 0.0074
51 POLYMYOSITIS 13 0.0073
52 VERTEBRAL FORAMINAL STENOSIS 6 0.0073
53 SEDATION 189 0.0072
54 RASH ERYTHEMATOUS 337 0.0070
55 MYOFASCIAL PAIN SYNDROME 5 0.0070
56 SPINAL STENOSIS 29 0.0070
57 AORTIC CALCIFICATION 4 0.0069
58 OTITIS MEDIA 21 0.0064
59 OSTEOPENIA 96 0.0063
60 DECREASED IMMUNE RESPONSIVENESS 61 0.0062
61 HEPATIC ENZYME INCREASED 422 0.0062
62 FLUID RETENTION 306 0.0060
63 BONE DENSITY ABNORMAL 22 0.0059
64 EXPOSURE DURING PREGNANCY 364 0.0059
65 EXOSTOSIS 52 0.0057
66 PRIMARY SEQUESTRUM 5 0.0055
67 NIGHTMARE 189 0.0055
68 INFUSION RELATED REACTION 334 0.0050
69 BREAST CALCIFICATIONS 4 0.0050
70 PERIODONTAL DISEASE 7 0.0050
71 RECTAL PROLAPSE 6 0.0050
72 TOOTH EROSION 6 0.0049
73 BONE MARROW OEDEMA 5 0.0048
74 CAROTID ARTERY DISEASE 6 0.0047
75 VASCULAR CALCIFICATION 5 0.0047
76 CYST 58 0.0047
77 HYPERHIDROSIS 594 0.0046
78 DEFORMITY 43 0.0046
79 MAJOR DEPRESSION 33 0.0045
80 PARAPLEGIA 13 0.0045
81 COMA 212 0.0044
82 PHARYNGEAL PARAESTHESIA 7 0.0044
83 FRUSTRATION TOLERANCE DECREASED 33 0.0041
84 POOR VENOUS ACCESS 42 0.0041
85 SPONDYLOLISTHESIS 7 0.0040
86 DRUG INTOLERANCE 389 0.0040
87 INFUSION SITE DISCHARGE 7 0.0040
88 SEDATION COMPLICATION 10 0.0039
89 ENTHESOPATHY 6 0.0038
90 ESSENTIAL HYPERTENSION 7 0.0038
91 BLOOD POTASSIUM INCREASED 62 0.0038
92 NEUROGENIC BLADDER 8 0.0038
93 HYPOVITAMINOSIS 5 0.0038
94 NEPHROLITHIASIS 171 0.0037
95 RHEUMATOID ARTHRITIS 423 0.0037
96 TREATMENT FAILURE 308 0.0037
97 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 19 0.0037
98 GUN SHOT WOUND 7 0.0037
99 MICTURITION URGENCY 42 0.0037
100 INTENTIONAL PRODUCT MISUSE 318 0.0036
101 NOCTURIA 44 0.0036
102 CATAPLEXY 5 0.0035
103 CONNECTIVE TISSUE DISORDER 5 0.0035
104 POST HERPETIC NEURALGIA 5 0.0035
105 ON AND OFF PHENOMENON 19 0.0034
106 KYPHOSIS 6 0.0034
107 PANCREATITIS CHRONIC 8 0.0034
108 MYASTHENIA GRAVIS CRISIS 5 0.0034
109 SINUS OPERATION 8 0.0034
110 ASTHMA 378 0.0033
111 JOINT SWELLING 403 0.0033
112 IMMUNE THROMBOCYTOPENIA 15 0.0033
113 ACCIDENTAL DEATH 6 0.0032
114 GASTROOESOPHAGEAL REFLUX DISEASE 258 0.0032
115 PRODUCT ADMINISTRATION INTERRUPTED 25 0.0032
116 BLOOD PRESSURE DIASTOLIC ABNORMAL 8 0.0031
117 CARPAL TUNNEL SYNDROME 44 0.0031
118 VITAMIN B12 DECREASED 9 0.0031
119 COLONIC POLYP 5 0.0030
120 PATHOLOGICAL GAMBLING 5 0.0030
121 VEIN RUPTURE 5 0.0030
122 SUSPECTED SUICIDE 14 0.0030
123 HYDROCEPHALUS 16 0.0029
124 OSTEOARTHRITIS 122 0.0029
125 RETCHING 61 0.0029
126 DIABETIC NEUROPATHY 14 0.0028
127 INTERVERTEBRAL DISC DEGENERATION 26 0.0028
128 HYPERSENSITIVITY 505 0.0027
129 BODY TEMPERATURE ABNORMAL 5 0.0027
130 FEELING COLD 75 0.0027
131 THROMBOCYTOPENIA 300 0.0027
132 COMPLETED SUICIDE 220 0.0026
133 NEURALGIA 63 0.0026
134 DECREASED INTEREST 15 0.0025
135 ADVERSE REACTION 33 0.0025
136 MENISCUS INJURY 15 0.0024
137 LABYRINTHITIS 6 0.0024
138 INTERVERTEBRAL DISC DISORDER 10 0.0023
139 ACUTE SINUSITIS 4 0.0023
140 FIBROMYALGIA 56 0.0023
141 SKIN LESION 63 0.0023
142 LIMB MASS 5 0.0023
143 GENERAL SYMPTOM 17 0.0023
144 OBSESSIVE-COMPULSIVE DISORDER 18 0.0022
145 MULTIPLE DRUG OVERDOSE INTENTIONAL 7 0.0022
146 SUSPECTED COVID-19 7 0.0021
147 SPINAL COLUMN STENOSIS 10 0.0021
148 SNORING 8 0.0021
149 BLOOD PRESSURE ABNORMAL 42 0.0021
150 SPINAL DISORDER 20 0.0021
151 DERMATITIS CONTACT 24 0.0021
152 HYPERTENSION 439 0.0021
153 LUMBAR SPINAL STENOSIS 6 0.0021
154 SPINAL OSTEOARTHRITIS 18 0.0020
155 PSORIASIS 266 0.0020
156 PRODUCT USE ISSUE 382 0.0020
157 CONSTIPATION 441 0.0020
158 INFECTION 292 0.0020
159 ILEUS PARALYTIC 9 0.0020
160 DIPLOPIA 51 0.0020
161 NEPHROGENIC ANAEMIA 9 0.0019
162 PRE-EXISTING CONDITION IMPROVED 12 0.0019
163 PARADOXICAL DRUG REACTION 7 0.0019
164 OVERDOSE 410 0.0019
165 NON-CARDIAC CHEST PAIN 6 0.0019
166 BUNDLE BRANCH BLOCK LEFT 8 0.0019
167 IMPULSIVE BEHAVIOUR 7 0.0019
168 INFUSION SITE HAEMORRHAGE 6 0.0018
169 DRY EYE 91 0.0018
170 SLEEP DISORDER 128 0.0018
171 SPINAL PAIN 21 0.0018
172 CALCINOSIS 4 0.0018
173 POST-TRAUMATIC STRESS DISORDER 12 0.0018
174 SUSPECTED OFF LABEL USE 8 0.0018
175 EAR DISORDER 8 0.0017
176 SYNOVIAL CYST 8 0.0017
177 HYPERTONIC BLADDER 5 0.0017
178 BREAKTHROUGH PAIN 4 0.0017
179 PRESYNCOPE 42 0.0017
180 DYSARTHRIA 65 0.0017
181 CAROTID ARTERY STENOSIS 6 0.0017
182 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
183 VAGINAL INFECTION 8 0.0017
184 MIGRAINE 162 0.0017
185 HYPERLIPIDAEMIA 20 0.0017
186 BRUXISM 9 0.0017
187 BACK PAIN 387 0.0017
188 MULTIPLE ALLERGIES 13 0.0017
189 AFFECTIVE DISORDER 13 0.0017
190 SOMNOLENCE 329 0.0016
191 DRUG ABUSER 10 0.0016
192 OCULAR DISCOMFORT 18 0.0016
193 DYSPHEMIA 7 0.0016
194 PARANASAL SINUS DISCOMFORT 6 0.0016
195 DYSPHORIA 8 0.0016
196 MYDRIASIS 20 0.0016
197 SOCIAL AVOIDANT BEHAVIOUR 9 0.0016
198 SPEECH DISORDER 81 0.0015
199 HIATUS HERNIA 20 0.0015
200 FACET JOINT SYNDROME 5 0.0015
201 BREAST ENLARGEMENT 5 0.0015
202 HYSTERECTOMY 13 0.0015
203 BLOOD POTASSIUM ABNORMAL 4 0.0015
204 THERAPEUTIC AGENT TOXICITY 5 0.0015
205 ANXIETY DISORDER 5 0.0015
206 BRAIN INJURY 15 0.0015
207 ALCOHOL POISONING 4 0.0015
208 TRIGEMINAL NEURALGIA 6 0.0015
209 BREAST MASS 10 0.0015
210 HOMICIDAL IDEATION 6 0.0015
211 BIPOLAR DISORDER 16 0.0015
212 WOUND INFECTION 16 0.0015
213 SCOLIOSIS 9 0.0015
214 ANAL INCONTINENCE 13 0.0014
215 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
216 DEPRESSIVE SYMPTOM 5 0.0014
217 INTERVERTEBRAL DISC PROTRUSION 31 0.0014
218 LIGAMENT SPRAIN 14 0.0014
219 SEASONAL ALLERGY 20 0.0014
220 SCAR 24 0.0014
221 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 24 0.0014
222 INFUSION SITE PAIN 18 0.0014
223 IMPAIRED GASTRIC EMPTYING 19 0.0014
224 PHOTOSENSITIVITY REACTION 23 0.0014
225 ERYTHEMA 286 0.0014
226 SUICIDAL IDEATION 127 0.0014
227 DRUG TOLERANCE 7 0.0014
228 OSTEOMYELITIS 25 0.0014
229 SOMNAMBULISM 9 0.0014
230 PROCEDURAL PAIN 38 0.0014
231 HYPOMANIA 5 0.0014
232 PRODUCT USE IN UNAPPROVED INDICATION 332 0.0013
233 NEUROPATHY PERIPHERAL 127 0.0013
234 PROTEIN TOTAL DECREASED 5 0.0013
235 DYSPHONIA 77 0.0013
236 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 72 0.0013
237 COMMUNICATION DISORDER 5 0.0013
238 COMPRESSION FRACTURE 7 0.0013
239 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
240 SPINAL OPERATION 16 0.0013
241 TOXICITY TO VARIOUS AGENTS 217 0.0013
242 SPINAL CORD COMPRESSION 5 0.0013
243 HAEMORRHOIDS 25 0.0013
244 SEXUAL DYSFUNCTION 15 0.0013
245 JAW DISORDER 7 0.0013
246 ANURIA 11 0.0013
247 ASTHENOPIA 7 0.0013
248 RESPIRATORY ACIDOSIS 5 0.0013
249 SLEEP APNOEA SYNDROME 24 0.0013
250 CEREBRAL ATROPHY 5 0.0013
251 IMPAIRED QUALITY OF LIFE 18 0.0013
252 VITAMIN D DEFICIENCY 12 0.0012
253 CARDIO-RESPIRATORY ARREST 51 0.0012
254 PAIN 742 0.0012
255 MENSTRUAL DISORDER 10 0.0012
256 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
257 END STAGE RENAL DISEASE 22 0.0012
258 CHOLECYSTITIS CHRONIC 8 0.0012
259 GASTROINTESTINAL DISORDER 107 0.0012
260 MUSCLE FATIGUE 5 0.0012
261 ACCIDENT 14 0.0012
262 HEADACHE 733 0.0012
263 CEREBRAL ISCHAEMIA 6 0.0012
264 PERIPHERAL VASCULAR DISORDER 6 0.0012
265 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
266 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
267 MONOPLEGIA 5 0.0011
268 RESPIRATORY DEPRESSION 14 0.0011
269 ARTHROPATHY 63 0.0011
270 PHYSICAL DISABILITY 5 0.0011
271 PURPURA 10 0.0011
272 PAIN IN JAW 32 0.0011
273 DIVERTICULUM 8 0.0011
274 BLOOD DISORDER 9 0.0011
275 ECONOMIC PROBLEM 17 0.0011
276 RENAL TUBULAR NECROSIS 11 0.0011
277 FACIAL PAIN 10 0.0011
278 SENSORY LOSS 9 0.0011
279 INFUSION SITE SWELLING 7 0.0011
280 BONE LESION 4 0.0011
281 LIVER FUNCTION TEST ABNORMAL 32 0.0011
282 GALACTORRHOEA 7 0.0011
283 ARTHRITIS INFECTIVE 5 0.0011
284 COORDINATION ABNORMAL 15 0.0011
285 PYREXIA 372 0.0011
286 PULMONARY MASS 16 0.0011
287 MUSCULOSKELETAL STIFFNESS 94 0.0011
288 INFUSION SITE ERYTHEMA 9 0.0011
289 ANGER 36 0.0011
290 MITRAL VALVE INCOMPETENCE 12 0.0011
291 DISTURBANCE IN ATTENTION 57 0.0011
292 CARDIOMEGALY 13 0.0011
293 WEIGHT FLUCTUATION 11 0.0011
294 ENDOMETRIOSIS 5 0.0010
295 MUSCULOSKELETAL DISCOMFORT 18 0.0010
296 HEAD INJURY 33 0.0010
297 SKIN ATROPHY 6 0.0010
298 SEROTONIN SYNDROME 20 0.0010
299 PYELONEPHRITIS 9 0.0010
300 POSTOPERATIVE WOUND INFECTION 7 0.0010
301 DYSPHAGIA 98 0.0010
302 DIZZINESS POSTURAL 10 0.0010
303 THERAPY PARTIAL RESPONDER 16 0.0010
304 EYE MOVEMENT DISORDER 7 0.0010
305 CENTRAL NERVOUS SYSTEM LESION 14 0.0010
306 ONYCHOCLASIS 7 0.0010
307 BLOOD CREATININE INCREASED 66 0.0010
308 PLEURISY 6 0.0010
309 RENAL CYST 8 0.0010
310 DEPRESSION 229 0.0010
311 GASTROINTESTINAL PAIN 11 0.0010
312 TOOTHACHE 18 0.0010
313 RHINITIS 8 0.0010
314 RESTLESS LEGS SYNDROME 18 0.0010
315 ORAL CANDIDIASIS 13 0.0010
316 ABDOMINAL DISTENSION 103 0.0010
317 MULTIPLE SCLEROSIS 47 0.0010
318 FEAR OF INJECTION 7 0.0010
319 THROAT IRRITATION 44 0.0010
320 SLUGGISHNESS 10 0.0010
321 LEUKOPENIA 49 0.0010
322 TINNITUS 45 0.0010
323 MUSCLE SPASTICITY 12 0.0010
324 FEMORAL NECK FRACTURE 5 0.0010
325 EAR DISCOMFORT 10 0.0010
326 HYPERAESTHESIA 8 0.0010
327 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
328 PANIC REACTION 7 0.0010
329 TRISMUS 5 0.0010
330 SPINAL COMPRESSION FRACTURE 8 0.0010
331 OFF LABEL USE 838 0.0010
332 BLOOD SODIUM DECREASED 18 0.0010
333 BALANCE DISORDER 82 0.0009
334 PERIPHERAL COLDNESS 13 0.0009
335 JOINT DISLOCATION 10 0.0009
336 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
337 HYPERCHOLESTEROLAEMIA 9 0.0009
338 ATELECTASIS 9 0.0009
339 ANAL ABSCESS 5 0.0009
340 STRESS FRACTURE 5 0.0009
341 HYPERPROLACTINAEMIA 6 0.0009
342 DELIRIUM 32 0.0009
343 TENDON DISORDER 6 0.0009
344 KIDNEY INFECTION 18 0.0009
345 TIC 5 0.0009
346 GAIT DISTURBANCE 175 0.0009
347 FAECALOMA 5 0.0009
348 URINARY INCONTINENCE 27 0.0009
349 RENAL FAILURE CHRONIC 7 0.0009
350 AUTISM SPECTRUM DISORDER 5 0.0009
351 CONCUSSION 7 0.0009
352 DENTAL CARIES 10 0.0009
353 PSYCHOMOTOR HYPERACTIVITY 15 0.0009
354 HEAD DISCOMFORT 16 0.0009
355 EAR INFECTION 24 0.0009
356 OVARIAN CYST 9 0.0009
357 MENTAL STATUS CHANGES 25 0.0009
358 DRY MOUTH 73 0.0009
359 GASTROINTESTINAL INFECTION 8 0.0009
360 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
361 BLOOD ALBUMIN DECREASED 7 0.0009
362 TRICUSPID VALVE INCOMPETENCE 7 0.0009
363 RASH 384 0.0009
364 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
365 NERVOUSNESS 46 0.0009
366 BONE DISORDER 16 0.0009
367 EAR PAIN 17 0.0009
368 GASTRITIS 23 0.0009
369 CELLULITIS 44 0.0009
370 TEMPERATURE INTOLERANCE 9 0.0009
371 HYPERSOMNIA 25 0.0009
372 MUSCLE ATROPHY 11 0.0009
373 HAIR GROWTH ABNORMAL 6 0.0009
374 FORMICATION 6 0.0009
375 MULTIPLE SCLEROSIS RELAPSE 59 0.0009
376 DECUBITUS ULCER 7 0.0009
377 RENAL IMPAIRMENT 72 0.0009
378 ROTATOR CUFF SYNDROME 11 0.0009
379 FEAR 23 0.0009
380 KNEE ARTHROPLASTY 18 0.0009
381 BLOOD TEST ABNORMAL 12 0.0009
382 EYE PAIN 48 0.0008
383 PHOTOPHOBIA 16 0.0008
384 URINE ODOUR ABNORMAL 5 0.0008
385 INSURANCE ISSUE 13 0.0008
386 ARTERIOSCLEROSIS 8 0.0008
387 HYPOTENSION 170 0.0008
388 JOINT INJURY 18 0.0008
389 HEMIPLEGIA 7 0.0008
390 EYE INFLAMMATION 8 0.0008
391 TOOTH INFECTION 11 0.0008
392 HYPONATRAEMIA 47 0.0008
393 SKIN LACERATION 9 0.0008
394 MENTAL IMPAIRMENT 20 0.0008
395 FAECES SOFT 6 0.0008
396 INADEQUATE ANALGESIA 7 0.0008
397 OESOPHAGITIS 9 0.0008
398 NECK PAIN 46 0.0008
399 APATHY 12 0.0008
400 ASPIRATION 9 0.0008
401 TREMOR 136 0.0008
402 VITAMIN D DECREASED 7 0.0008
403 PHARYNGEAL SWELLING 8 0.0008
404 OBESITY 13 0.0008
405 LIVER INJURY 20 0.0008
406 FATIGUE 633 0.0008
407 PSYCHIATRIC SYMPTOM 6 0.0008
408 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
409 SENSORY DISTURBANCE 13 0.0008
410 TENDON RUPTURE 10 0.0008
411 MOBILITY DECREASED 58 0.0008
412 THERAPEUTIC PRODUCT EFFECT DECREASED 36 0.0008
413 MUSCLE TIGHTNESS 13 0.0008
414 IMPAIRED WORK ABILITY 17 0.0008
415 FOOT FRACTURE 15 0.0008
416 MANIA 13 0.0008
417 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
418 DISCOMFORT 48 0.0008
419 LOCALISED INFECTION 19 0.0008
420 UNDERDOSE 57 0.0008
421 FALL 259 0.0008
422 RIB FRACTURE 16 0.0008
423 PROCTALGIA 5 0.0008
424 CARDIAC FLUTTER 5 0.0008
425 TYPE 2 DIABETES MELLITUS 26 0.0008
426 TRANSIENT ISCHAEMIC ATTACK 26 0.0008
427 NAUSEA 605 0.0008
428 PAIN IN EXTREMITY 225 0.0008
429 HYPOAESTHESIA 114 0.0008
430 MYELODYSPLASTIC SYNDROME 11 0.0008
431 ORAL PAIN 17 0.0008
432 ATAXIA 9 0.0008
433 WALKING AID USER 5 0.0008
434 DEPRESSED MOOD 40 0.0008
435 MYOCLONUS 9 0.0008
436 ULCER 12 0.0008
437 INTENTIONAL PRODUCT USE ISSUE 66 0.0008
438 EATING DISORDER 16 0.0008
439 MENINGITIS 5 0.0007
440 URINARY TRACT INFECTION 127 0.0007
441 LACERATION 7 0.0007
442 LIMB DISCOMFORT 23 0.0007
443 WRONG PRODUCT ADMINISTERED 5 0.0007
444 FAECES DISCOLOURED 16 0.0007
445 INSOMNIA 196 0.0007
446 BACK INJURY 8 0.0007
447 SKIN ULCER 19 0.0007
448 DIABETES MELLITUS 56 0.0007
449 POLYURIA 6 0.0007
450 DYSPEPSIA 72 0.0007
451 ANXIETY 208 0.0007
452 SUICIDE ATTEMPT 44 0.0007
453 PHARYNGITIS 9 0.0007
454 JOINT EFFUSION 5 0.0007
455 SINUS BRADYCARDIA 7 0.0007
456 ENCEPHALITIS 5 0.0007
457 GASTROENTERITIS VIRAL 13 0.0007
458 ORAL DISCOMFORT 10 0.0007
459 NERVE INJURY 8 0.0007
460 HUNGER 10 0.0007
461 INTENTIONAL DRUG MISUSE 15 0.0007
462 APHONIA 10 0.0007
463 EXTRASYSTOLES 5 0.0007
464 BRONCHITIS 53 0.0007
465 EMOTIONAL DISORDER 22 0.0007
466 HERPES ZOSTER 41 0.0007
467 SKIN INFECTION 8 0.0007
468 KNEE OPERATION 7 0.0007
469 ACCIDENTAL OVERDOSE 26 0.0007
470 CHRONIC KIDNEY DISEASE 54 0.0007
471 LYMPHADENOPATHY 25 0.0007
472 MEMORY IMPAIRMENT 97 0.0007
473 SINUSITIS 72 0.0007
474 HYPOTONIA 7 0.0007
475 SPINAL FRACTURE 14 0.0007
476 BLOOD POTASSIUM DECREASED 21 0.0007
477 BLOOD MAGNESIUM DECREASED 6 0.0007
478 SCIATICA 11 0.0007
479 THERAPY NON-RESPONDER 31 0.0007
480 RESPIRATORY ARREST 19 0.0007
481 VERTIGO 42 0.0007
482 WEIGHT INCREASED 154 0.0007
483 BLOOD CHOLESTEROL INCREASED 32 0.0007
484 MUSCULAR WEAKNESS 78 0.0007
485 UTERINE LEIOMYOMA 5 0.0007
486 SENSITIVE SKIN 5 0.0007
487 BACK DISORDER 11 0.0007
488 TOOTH DISORDER 15 0.0007
489 NEUROLEPTIC MALIGNANT SYNDROME 8 0.0007
490 TENDERNESS 7 0.0007
491 DRUG INEFFECTIVE 884 0.0007
492 ELECTROCARDIOGRAM QT PROLONGED 24 0.0007
493 VENTRICULAR TACHYCARDIA 11 0.0007
494 SURGERY 39 0.0007
495 HYPOPHAGIA 17 0.0007
496 CONVULSION 38 0.0007
497 LIMB INJURY 18 0.0007
498 APHASIA 20 0.0007
499 INCONTINENCE 7 0.0007
500 LACRIMATION INCREASED 20 0.0007
501 DRUG TOXICITY 9 0.0007
502 URINARY RETENTION 22 0.0007
503 BLOOD UREA INCREASED 11 0.0007
504 BODY HEIGHT DECREASED 7 0.0007
505 HIP FRACTURE 21 0.0007
506 IRRITABLE BOWEL SYNDROME 14 0.0007
507 BOWEL MOVEMENT IRREGULARITY 5 0.0007
508 NERVE COMPRESSION 6 0.0006
509 HYPERCALCAEMIA 8 0.0006
510 HEART RATE INCREASED 64 0.0006
511 WITHDRAWAL SYNDROME 27 0.0006
512 APNOEA 5 0.0006
513 INTESTINAL OBSTRUCTION 24 0.0006
514 SINUS TACHYCARDIA 9 0.0006
515 PALPITATIONS 74 0.0006
516 VENTRICULAR FIBRILLATION 7 0.0006
517 FUNGAL INFECTION 21 0.0006
518 MOOD SWINGS 20 0.0006
519 AGITATION 46 0.0006
520 ACUTE RESPIRATORY FAILURE 12 0.0006
521 MOVEMENT DISORDER 20 0.0006
522 DERMATITIS 13 0.0006
523 HEART RATE IRREGULAR 14 0.0006
524 MYASTHENIA GRAVIS 5 0.0006
525 APPLICATION SITE VESICLES 4 0.0006
526 GASTROENTERITIS 9 0.0006
527 ANGINA UNSTABLE 4 0.0006
528 PARKINSONISM 6 0.0006
529 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 32 0.0006
530 GASTRIC DISORDER 21 0.0006
531 CHOLELITHIASIS 20 0.0006
532 BODY TEMPERATURE DECREASED 6 0.0006
533 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
534 IMMUNE SYSTEM DISORDER 8 0.0006
535 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
536 APPETITE DISORDER 4 0.0006
537 POST PROCEDURAL HAEMORRHAGE 7 0.0006
538 POLLAKIURIA 25 0.0006
539 BURNING SENSATION 42 0.0006
540 DYSURIA 22 0.0006
541 HAEMODIALYSIS 5 0.0006
542 BRONCHIECTASIS 4 0.0006
543 SENSATION OF FOREIGN BODY 5 0.0006
544 DRUG INTERACTION 94 0.0006
545 SINUS CONGESTION 8 0.0006
546 CONTUSION 57 0.0006
547 EYELID PTOSIS 6 0.0006
548 MOTOR DYSFUNCTION 6 0.0006
549 DRUG ABUSE 49 0.0006
550 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
551 BLOOD PRESSURE FLUCTUATION 14 0.0006
552 MUSCULOSKELETAL CHEST PAIN 9 0.0006
553 DIZZINESS 289 0.0006
554 CRYING 21 0.0006
555 DIVERTICULITIS 16 0.0006
556 PANIC ATTACK 21 0.0006
557 PSYCHOTIC DISORDER 17 0.0006
558 AUTOIMMUNE HEPATITIS 4 0.0006
559 POST PROCEDURAL COMPLICATION 11 0.0006
560 GLAUCOMA 11 0.0006
561 LOSS OF CONSCIOUSNESS 73 0.0006
562 GROIN PAIN 5 0.0006
563 BLOOD PRESSURE INCREASED 87 0.0006
564 GAIT INABILITY 19 0.0006
565 BLINDNESS UNILATERAL 8 0.0006
566 OSTEONECROSIS OF JAW 14 0.0006
567 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
568 MUSCLE TWITCHING 13 0.0006
569 THERAPEUTIC RESPONSE DECREASED 34 0.0006
570 THIRST 10 0.0006
571 THROMBOSIS 45 0.0006
572 INFLUENZA LIKE ILLNESS 46 0.0006
573 ANGINA PECTORIS 16 0.0006
574 GOUT 10 0.0006
575 THERAPEUTIC RESPONSE UNEXPECTED 25 0.0006
576 POISONING 7 0.0006
577 ADVERSE DRUG REACTION 50 0.0006
578 DERMATITIS ALLERGIC 7 0.0006
579 HEAVY MENSTRUAL BLEEDING 5 0.0006
580 AMNESIA 36 0.0006
581 OEDEMA 30 0.0006
582 HYPOKINESIA 8 0.0006
583 OPTIC NEURITIS 5 0.0005
584 IMPAIRED HEALING 18 0.0005
585 WEIGHT DECREASED 153 0.0005
586 INFLUENZA 61 0.0005
587 PRODUCTIVE COUGH 26 0.0005
588 INCREASED TENDENCY TO BRUISE 5 0.0005
589 BLINDNESS TRANSIENT 4 0.0005
590 UROSEPSIS 5 0.0005
591 GRAND MAL CONVULSION 5 0.0005
592 COAGULOPATHY 9 0.0005
593 ARTHROPOD BITE 4 0.0005
594 MUSCLE SPASMS 99 0.0005
595 PRODUCT DISTRIBUTION ISSUE 5 0.0005
596 CATARACT 32 0.0005
597 HEPATIC STEATOSIS 10 0.0005
598 DEAFNESS 14 0.0005
599 APPENDICITIS 5 0.0005
600 PARAESTHESIA 84 0.0005
601 ILLNESS 55 0.0005
602 CYSTITIS 17 0.0005
603 VISION BLURRED 73 0.0005
604 STATUS EPILEPTICUS 6 0.0005
605 CHEST PAIN 97 0.0005
606 INCREASED APPETITE 10 0.0005
607 DEVICE RELATED INFECTION 8 0.0005
608 ANKLE FRACTURE 8 0.0005
609 DYSKINESIA 21 0.0005
610 CONDITION AGGRAVATED 157 0.0005
611 UNEVALUABLE EVENT 39 0.0005
612 CHOKING 10 0.0005
613 LIVER FUNCTION TEST INCREASED 11 0.0005
614 SEIZURE 59 0.0005
615 COLD SWEAT 9 0.0005
616 TACHYCARDIA 45 0.0005
617 EYE PRURITUS 17 0.0005
618 BLOOD IRON DECREASED 6 0.0005
619 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
620 SINUS DISORDER 10 0.0005
621 UNRESPONSIVE TO STIMULI 13 0.0005
622 RESPIRATORY TRACT CONGESTION 8 0.0005
623 UPPER LIMB FRACTURE 10 0.0005
624 ATRIAL FLUTTER 4 0.0005
625 HYPOTHYROIDISM 16 0.0005
626 MASS 7 0.0005
627 WRIST FRACTURE 6 0.0005
628 BLOOD PRESSURE DECREASED 33 0.0005
629 TARDIVE DYSKINESIA 14 0.0005
630 ARTHRITIS 39 0.0005
631 EMPHYSEMA 5 0.0005
632 CONFUSIONAL STATE 80 0.0005
633 RENAL FAILURE ACUTE 21 0.0005
634 DEHYDRATION 66 0.0005
635 HYPOTHERMIA 5 0.0005
636 ARTHRALGIA 205 0.0005
637 COGNITIVE DISORDER 23 0.0005
638 DRUG LEVEL DECREASED 5 0.0005
639 HALLUCINATION 37 0.0005
640 SUBDURAL HAEMATOMA 7 0.0005
641 OSTEOPOROSIS 20 0.0005
642 OEDEMA PERIPHERAL 59 0.0005
643 MATERNAL EXPOSURE DURING PREGNANCY 43 0.0005
644 PULMONARY HYPERTENSION 10 0.0005
645 SYNCOPE 48 0.0005
646 PETECHIAE 5 0.0005
647 ROAD TRAFFIC ACCIDENT 20 0.0005
648 PRODUCT ODOUR ABNORMAL 5 0.0005
649 MUSCULOSKELETAL PAIN 25 0.0005
650 BLOOD URINE PRESENT 9 0.0005
651 SCRATCH 5 0.0005
652 MUSCULOSKELETAL DISORDER 9 0.0005
653 INTRAOCULAR PRESSURE INCREASED 6 0.0005
654 HOSPITALISATION 72 0.0005
655 ERECTILE DYSFUNCTION 12 0.0005
656 GENERAL PHYSICAL HEALTH DETERIORATION 54 0.0005
657 HAEMOPTYSIS 13 0.0005
658 HEREDITARY ANGIOEDEMA 5 0.0005
659 PRODUCT DOSE OMISSION ISSUE 137 0.0005
660 HERNIA 9 0.0005
661 DEMENTIA 13 0.0005
662 DYSTONIA 9 0.0005
663 CORONARY ARTERY DISEASE 14 0.0005
664 PHARYNGITIS STREPTOCOCCAL 5 0.0005
665 DEVICE FAILURE 7 0.0005
666 RENAL FAILURE 61 0.0005
667 PRODUCT PRESCRIBING ISSUE 10 0.0005
668 MYALGIA 78 0.0005
669 MYOCARDIAL INFARCTION 80 0.0005
670 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
671 DIABETIC KETOACIDOSIS 11 0.0005
672 FEELING HOT 28 0.0005
673 ANHEDONIA 12 0.0005
674 EYE DISORDER 15 0.0005
675 BLOOD CALCIUM INCREASED 4 0.0005
676 ANKYLOSING SPONDYLITIS 6 0.0005
677 FEELING ABNORMAL 109 0.0005
678 INJECTION SITE NODULE 5 0.0005
679 SARS-COV-2 TEST POSITIVE 6 0.0005
680 THYROID DISORDER 7 0.0005
681 TOOTH FRACTURE 5 0.0005
682 TENDONITIS 7 0.0005
683 DYSPNOEA EXERTIONAL 17 0.0005
684 ASTHENIA 169 0.0004
685 NERVOUS SYSTEM DISORDER 14 0.0004
686 GALLBLADDER DISORDER 8 0.0004
687 MALNUTRITION 5 0.0004
688 CYANOSIS 7 0.0004
689 FISTULA 5 0.0004
690 BLOOD CALCIUM DECREASED 5 0.0004
691 COVID-19 78 0.0004
692 EXTRAPYRAMIDAL DISORDER 11 0.0004
693 FLUSHING 45 0.0004
694 NASAL CONGESTION 26 0.0004
695 BODY TEMPERATURE INCREASED 9 0.0004
696 INJURY 31 0.0004
697 PRODUCT AVAILABILITY ISSUE 10 0.0004
698 HYPERGLYCAEMIA 16 0.0004
699 CHOLECYSTECTOMY 5 0.0004
700 RESTLESSNESS 16 0.0004
701 MENTAL DISORDER 19 0.0004
702 INTENTIONAL OVERDOSE 28 0.0004
703 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
704 SKIN DISCOLOURATION 20 0.0004
705 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
706 LETHARGY 25 0.0004
707 EYE SWELLING 16 0.0004
708 ABDOMINAL PAIN 100 0.0004
709 BONE PAIN 25 0.0004
710 INFLAMMATION 22 0.0004
711 EXPOSURE VIA SKIN CONTACT 11 0.0004
712 MALAISE 186 0.0004
713 PHARMACEUTICAL PRODUCT COMPLAINT 11 0.0004
714 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
715 RESPIRATORY TRACT INFECTION 11 0.0004
716 THERAPEUTIC RESPONSE SHORTENED 14 0.0004
717 DIARRHOEA 271 0.0004
718 FEELING JITTERY 8 0.0004
719 CHOLECYSTITIS 5 0.0004
720 ACUTE KIDNEY INJURY 64 0.0004
721 MUSCLE RIGIDITY 5 0.0004
722 ABDOMINAL DISCOMFORT 70 0.0004
723 DEEP VEIN THROMBOSIS 27 0.0004
724 PNEUMONIA 134 0.0004
725 ERUCTATION 8 0.0004
726 HOT FLUSH 31 0.0004
727 DYSSTASIA 12 0.0004
728 AUTOIMMUNE DISORDER 4 0.0004
729 NO THERAPEUTIC RESPONSE 5 0.0004
730 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
731 PARANOIA 7 0.0004
732 CARDIOMYOPATHY 6 0.0004
733 FLATULENCE 23 0.0004
734 DRUG WITHDRAWAL SYNDROME NEONATAL 6 0.0004
735 MULTI-ORGAN FAILURE 7 0.0004
736 DYSGEUSIA 30 0.0004
737 DISORIENTATION 16 0.0004
738 VISUAL IMPAIRMENT 50 0.0004
739 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
740 ARRHYTHMIA 19 0.0004
741 INJECTION SITE DISCOLOURATION 5 0.0004
742 AGGRESSION 20 0.0004
743 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 72 0.0004
744 SECRETION DISCHARGE 5 0.0004
745 IRRITABILITY 24 0.0004
746 ABDOMINAL PAIN UPPER 82 0.0004
747 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
748 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
749 RECTAL HAEMORRHAGE 17 0.0004
750 STAPHYLOCOCCAL INFECTION 13 0.0004
751 DRUG DISPENSING ERROR 6 0.0004
752 HEPATITIS 10 0.0004
753 VIRAL INFECTION 13 0.0004
754 PHARYNGEAL OEDEMA 6 0.0004
755 EMOTIONAL DISTRESS 47 0.0004
756 URTICARIA 65 0.0004
757 ANOREXIA 5 0.0004
758 PLATELET COUNT DECREASED 41 0.0004
759 SWOLLEN TONGUE 12 0.0004
760 BEDRIDDEN 5 0.0004
761 MOUTH ULCERATION 8 0.0004
762 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
763 HALLUCINATION, VISUAL 8 0.0004
764 ABNORMAL BEHAVIOUR 15 0.0004
765 PRODUCT PRESCRIBING ERROR 9 0.0004
766 CONJUNCTIVITIS 7 0.0004
767 ABSCESS 6 0.0004
768 CHILLS 44 0.0004
769 METABOLIC ACIDOSIS 12 0.0004
770 BREAST PAIN 4 0.0004
771 MIDDLE INSOMNIA 7 0.0004
772 CARDIAC DISORDER 35 0.0004
773 CARDIAC FAILURE 30 0.0004
774 MALIGNANT MELANOMA 5 0.0004
775 JOINT RANGE OF MOTION DECREASED 5 0.0004
776 VOMITING 175 0.0004
777 POOR QUALITY SLEEP 8 0.0004
778 RHINORRHOEA 24 0.0004
779 PRODUCT TASTE ABNORMAL 5 0.0004
780 PULMONARY EMBOLISM 35 0.0004
781 SEPTIC SHOCK 16 0.0004
782 ENCEPHALOPATHY 9 0.0004
783 AKATHISIA 5 0.0004
784 GINGIVAL BLEEDING 5 0.0004
785 TREATMENT NONCOMPLIANCE 20 0.0004
786 LOWER LIMB FRACTURE 7 0.0004
787 APPLICATION SITE RASH 5 0.0004
788 PERIPHERAL SWELLING 56 0.0004
789 CARDIAC ARREST 30 0.0004
790 LIVER DISORDER 16 0.0004
791 LIP SWELLING 12 0.0004
792 PRURITUS 138 0.0004
793 ORAL HERPES 7 0.0004
794 C-REACTIVE PROTEIN INCREASED 13 0.0004
795 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
796 OROPHARYNGEAL PAIN 33 0.0004
797 ABDOMINAL PAIN LOWER 9 0.0004
798 FACE OEDEMA 6 0.0004
799 CANDIDA INFECTION 6 0.0004
800 DRUG EFFECT DECREASED 19 0.0004
801 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
802 INJECTION SITE MASS 13 0.0004
803 HAEMATURIA 12 0.0004
804 PRODUCT SUBSTITUTION ISSUE 20 0.0003
805 PRODUCT PHYSICAL ISSUE 7 0.0003
806 PRODUCT ADMINISTRATION ERROR 7 0.0003
807 ORTHOSTATIC HYPOTENSION 6 0.0003
808 LOCAL SWELLING 6 0.0003
809 LUNG NEOPLASM MALIGNANT 14 0.0003
810 LYMPHOCYTE COUNT DECREASED 6 0.0003
811 ACUTE MYOCARDIAL INFARCTION 10 0.0003
812 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
813 OXYGEN SATURATION DECREASED 19 0.0003
814 TOOTH LOSS 7 0.0003
815 OCULAR HYPERAEMIA 16 0.0003
816 NASOPHARYNGITIS 62 0.0003
817 CARDIAC FAILURE CONGESTIVE 27 0.0003
818 RESPIRATORY DISORDER 10 0.0003
819 SYNOVITIS 6 0.0003
820 BONE LOSS 5 0.0003
821 DECREASED APPETITE 77 0.0003
822 SWELLING 31 0.0003
823 PALLOR 9 0.0003
824 PELVIC PAIN 6 0.0003
825 SKIN DISORDER 11 0.0003
826 PLEURAL EFFUSION 20 0.0003
827 DYSPNOEA 186 0.0003
828 COUGH 92 0.0003
829 LUNG DISORDER 16 0.0003
830 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
831 FEMUR FRACTURE 10 0.0003
832 THINKING ABNORMAL 6 0.0003
833 WOUND 9 0.0003
834 PANCREATITIS 17 0.0003
835 BACTERIAL INFECTION 6 0.0003
836 EPISTAXIS 24 0.0003
837 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
838 BASAL CELL CARCINOMA 5 0.0003
839 ANAEMIA 61 0.0003
840 HEPATIC CIRRHOSIS 6 0.0003
841 DRUG WITHDRAWAL SYNDROME 28 0.0003
842 SICKLE CELL ANAEMIA WITH CRISIS 5 0.0003
843 FRACTURE 6 0.0003
844 GASTRIC ULCER 6 0.0003
845 INTENTIONAL DOSE OMISSION 9 0.0003
846 PNEUMOTHORAX 5 0.0003
847 ADVERSE EVENT 29 0.0003
848 RASH MACULAR 11 0.0003
849 EYE IRRITATION 18 0.0003
850 BLOOD GLUCOSE DECREASED 15 0.0003
851 RASH PAPULAR 7 0.0003
852 HAEMOGLOBIN DECREASED 32 0.0003
853 ANAPHYLACTIC REACTION 17 0.0003
854 JOINT STIFFNESS 8 0.0003
855 BLISTER 17 0.0003
856 HAEMATOCRIT DECREASED 6 0.0003
857 DRUG LEVEL INCREASED 5 0.0003
858 RESPIRATORY FAILURE 22 0.0003
859 BRADYCARDIA 16 0.0003
860 INJECTION SITE BRUISING 24 0.0003
861 PERICARDITIS 5 0.0003
862 HAEMORRHAGE 31 0.0003
863 THROAT TIGHTNESS 8 0.0003
864 HEMIPARESIS 5 0.0003
865 CEREBROVASCULAR ACCIDENT 50 0.0003
866 CIRCULATORY COLLAPSE 5 0.0003
867 SWELLING FACE 19 0.0003
868 PULMONARY OEDEMA 13 0.0003
869 COLITIS 11 0.0003
870 ABNORMAL DREAMS 8 0.0003
871 HYPOGLYCAEMIA 14 0.0003
872 SEPSIS 32 0.0003
873 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
874 DERMATITIS ATOPIC 15 0.0003
875 ABASIA 7 0.0003
876 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
877 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
878 BRONCHOSPASM 4 0.0003
879 ILL-DEFINED DISORDER 17 0.0003
880 NIGHT SWEATS 9 0.0003
881 ALOPECIA 54 0.0003
882 PSORIATIC ARTHROPATHY 11 0.0003
883 VISUAL ACUITY REDUCED 9 0.0003
884 GLOSSODYNIA 6 0.0003
885 ECZEMA 14 0.0003
886 THERAPY INTERRUPTED 19 0.0003
887 CHROMATURIA 6 0.0003
888 INJECTION SITE PAIN 81 0.0003
889 RHABDOMYOLYSIS 11 0.0003
890 DRUG PRESCRIBING ERROR 5 0.0003
891 HYPOKALAEMIA 12 0.0003
892 FREQUENT BOWEL MOVEMENTS 7 0.0003
893 RASH PRURITIC 14 0.0003
894 RENAL DISORDER 12 0.0003
895 MOOD ALTERED 7 0.0003
896 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
897 BONE DENSITY DECREASED 8 0.0003
898 BRAIN FOG 4 0.0003
899 CHEST DISCOMFORT 26 0.0003
900 RESPIRATORY DISTRESS 7 0.0003
901 PRESCRIBED UNDERDOSE 5 0.0003
902 INJECTION SITE ERYTHEMA 31 0.0002
903 STOMATITIS 15 0.0002
904 DRY SKIN 33 0.0002
905 DRUG DEPENDENCE 39 0.0002
906 AGEUSIA 6 0.0002
907 ATRIAL FIBRILLATION 23 0.0002
908 HYPOACUSIS 10 0.0002
909 SKIN CANCER 5 0.0002
910 HEPATIC FAILURE 7 0.0002
911 RASH GENERALISED 6 0.0002
912 PRURITUS GENERALISED 5 0.0002
913 PLASMA CELL MYELOMA 9 0.0002
914 HEART RATE DECREASED 8 0.0002
915 HYPOXIA 8 0.0002
916 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
917 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
918 HEPATOTOXICITY 5 0.0002
919 INJECTION SITE PRURITUS 15 0.0002
920 DEVICE ISSUE 20 0.0002
921 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
922 DEPENDENCE 12 0.0002
923 INJECTION SITE REACTION 15 0.0002
924 BLOOD GLUCOSE ABNORMAL 4 0.0002
925 MEDICATION ERROR 12 0.0002
926 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
927 ACNE 16 0.0002
928 RED BLOOD CELL COUNT DECREASED 6 0.0002
929 BLOOD GLUCOSE INCREASED 39 0.0002
930 CEREBRAL INFARCTION 5 0.0002
931 ASCITES 6 0.0002
932 WHEEZING 12 0.0002
933 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 41 0.0002
934 RENAL INJURY 6 0.0002
935 COLITIS ULCERATIVE 9 0.0002
936 NEOPLASM PROGRESSION 7 0.0002
937 HAEMATOCHEZIA 11 0.0002
938 INJECTION SITE SWELLING 15 0.0002
939 CEREBRAL HAEMORRHAGE 7 0.0002
940 HAEMATOMA 5 0.0002
941 MUCOSAL INFLAMMATION 5 0.0002
942 APPLICATION SITE ERYTHEMA 5 0.0002
943 VAGINAL HAEMORRHAGE 8 0.0002
944 PNEUMONITIS 5 0.0002
945 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
946 BREAST CANCER 17 0.0002
947 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
948 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
949 DISEASE PROGRESSION 21 0.0002
950 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
951 APPLICATION SITE PRURITUS 4 0.0002
952 THERAPY CESSATION 9 0.0002
953 INJECTION SITE HAEMORRHAGE 14 0.0002
954 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
955 ABORTION SPONTANEOUS 7 0.0002
956 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
957 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
958 NEEDLE ISSUE 5 0.0002
959 NEUTROPHIL COUNT DECREASED 7 0.0002
960 HYPERKALAEMIA 6 0.0002
961 PREMATURE BABY 5 0.0002
962 SKIN EXFOLIATION 14 0.0002
963 DRUG EFFECT INCOMPLETE 6 0.0002
964 EPILEPSY 5 0.0002
965 DRUG ADMINISTRATION ERROR 5 0.0002
966 PRODUCT QUALITY ISSUE 21 0.0002
967 OSTEONECROSIS 5 0.0002
968 INCORRECT DOSE ADMINISTERED 34 0.0001
969 EXTRA DOSE ADMINISTERED 6 0.0001
970 BLINDNESS 6 0.0001
971 DRUG DOSE OMISSION 24 0.0001
972 SKIN BURNING SENSATION 10 0.0001
973 PRODUCT DOSE OMISSION 9 0.0001
974 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
975 NEOPLASM MALIGNANT 9 0.0001
976 DISEASE RECURRENCE 6 0.0001
977 PANCYTOPENIA 7 0.0001
978 DEVICE BREAKAGE 5 0.0001
979 NO ADVERSE EVENT 22 0.0001
980 DEATH 102 0.0001
981 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
982 DEVICE DISLOCATION 5 0.0001
983 DEVICE MALFUNCTION 8 0.0001
984 ANGIOEDEMA 5 0.0001
985 INTERSTITIAL LUNG DISEASE 5 0.0001
986 PRODUCT STORAGE ERROR 9 0.0001
987 FEBRILE NEUTROPENIA 6 0.0001
988 NEUTROPENIA 11 0.0001
989 DEVICE EXPULSION 5 0.0001